This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 2003.
Company Filing History:
Years Active: 2003
Title: Christine Feinle: Innovator in Pharmaceutical Composition
Introduction
Christine Feinle is a notable inventor based in Adelaide, Australia. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of dyspepsia. Her innovative approach has led to the development of a unique pharmaceutical composition that addresses this common digestive issue.
Latest Patents
Christine Feinle holds 1 patent for her invention titled "Pharmaceutical composition and method for treatment of dyspepsia." This invention relates to compositions containing lipase inhibitors, such as orlistat, and their use in treating, reducing, or preventing functional dyspepsia after the ingestion of meals, especially those that are fat-rich.
Career Highlights
Throughout her career, Christine has been associated with Hoffmann-La Roche Inc., where she has been able to apply her expertise in pharmaceutical sciences. Her work has been instrumental in advancing treatment options for patients suffering from dyspepsia.
Collaborations
Christine has collaborated with esteemed colleagues, including Michael Fried and Hans Lengsfeld, to further enhance her research and development efforts in the pharmaceutical industry.
Conclusion
Christine Feinle's contributions to the field of pharmaceuticals, particularly in the treatment of dyspepsia, highlight her innovative spirit and dedication to improving patient care. Her work continues to inspire advancements in medical treatments.